Decline of anti-desmoglein 1 IgG ELISA scores by withdrawal of D-penicillamine in drug-induced pemphigus foliaceus

Clinical and Experimental Dermatology

Volumn 30, Issue 1, 2005, Pages 43-45

  Nagao, K ^a   Tanikawa, A ^a   Yamamoto, N ^a   Amagai, M ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CLOBETASOL PROPIONATE; DESMOGLEIN 1; DESMOGLEIN 1 IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; PENICILLAMINE; PREDNISOLONE; UNCLASSIFIED DRUG;

AGED; ARTICLE; CASE REPORT; DRUG ERUPTION; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; PEMPHIGUS FOLIACEUS; PRIORITY JOURNAL; SCORING SYSTEM; SKIN DEFECT; SYSTEMIC SCLEROSIS;

AGED; ANTIRHEUMATIC AGENTS; AUTOANTIBODIES; CADHERINS; DESMOGLEIN 1; DRUG ERUPTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; PEMPHIGUS; PENICILLAMINE; SCLEROSIS;

EID: 13244272023     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2004.01655.x     Document Type: Article

References (12)

1. Amagai M, Klaus-Kovtun V, Stanley J. Auto antibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell 1991; 67: 869-77.
2. Amagai M, Hashimoto T, Green K et al. Antigen specific immunoabsorption of pathogenic autoantibodies in pemphigus foliaceus. J Invest Dermatol 1995; 104: 895-901.
3. Amagai M, Nishikawa T, Nousari H et al. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice. J Clin Invest 1998; 102: 775-82.
4. Korman N, Eyre R, Zone J et al. Drug-induced pemphigus: autoantibodies directed against the pemphigus antigen complexes are present in penicillamine and captopril-induced pemphigus. J Invest Dermatol 1991; 96: 273-6.
5. Brenner S, Bialy-Golan A, Anhalt G. Recognition of pemphigus antigens in drug induced pemphigus vulgaris and pemphigus foliaceus. J Am Acad Dermatol 1997; 36: 919-23.
6. Davies M, Holt P. Pemphigus in a patient treated with penicillamine for generalized morphea. Arch Dermatol 1976; 112: 1308-9.
7. Brenner S, Bialy-Golan A, Ruocco V. Drug-induced pemphigus. Clin Dermatol 1998; 16: 393-7.
8. Jan V, Callens A, Machet L et al. o-penicillamine-induced pemphigus, polymyositis and myasthenia. Ann Dermatol Venereol 1999; 126: 153-6.
9. Alarcon-Segovia D. Drug-induced lupus syndromes. Mayo Clin Proc 1969; 44: 644-81.
10. Champion R, Burton JSM, Burns D, eds. Rook/Wilkinson/Ebling Textbook of Dermatology. 6th edn, Vol. 3. Oxford: Blackwell Science Ltd 1998.
11. 14C- labeled D-penicillamine (ii) metabolism and absorption, distribution and excretion after repeated administration in rats. Pharmacometrics 1977; 14: 277-87.
12. Wei P, Sass-Kortska A. Urinary excretion and renal clearance of D-penicillamine in human and dog. Gastroenterology 1970; 58: 288.